Press "Enter" to skip to content

Exclusive Report on Diabetes Care Devices Market 2019 | Industry Drivers, Business Plans, Types, Applications, Challenges, Opportunities and Latest Trends Forecast to 2024

Diabetes

The “Diabetes Care Devices Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Diabetes Care Devices industry. The information available in the Diabetes Care Devices market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Diabetes Care Devices market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Diabetes Care Devices Market:

  • Abbott Diabetes Care
  • Roche
  • Johnson & Johnson
  • Dexcom
  • Medtronic
  • Arkray
  • Ascensia Diabetes Care
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon
  • Medisana
  • Trivida
  • Rossmax

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999757

    Market Overview:

  • The global diabetes care devices market is expected to register a CAGR of about 6.8% during the forecast period (2019 – 2023).
  • Asia-Pacific is anticipated to dominate the market during the forecast period, owing to rising prevalence of obesity in the region.
  • There has been a significant rise in insulin delivery systems technology, from insulin injections to insulin pumps.
  • Technological innovations and advances give much convenience in measuring the blood glucose levels. One such advancement in monitoring the blood glucose levels is established with continuous glucose monitoring devices.

    Scope of the Report:

  • The global diabetes care devices market is segmented by management devices (insulin pumps, insulin pens, syringes, cartridges, and jet injectors) and monitoring devices (self-monitoring blood glucose (hospital and personal use) and continuous glucose monitoring), and geography.

    Reasons for Buying Diabetes Care Devices Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999757

    Key Market Trends: – Rising Prevalence of Diabetes

    As per a WHO report, the global prevalence of diabetes among adults of over 18 years accelerated from about 4.7%, in 1980, to over 8.5%, in 2014.
    Diabetes prevalence has been rising rapidly in the middle- and low-income countries. In 2015, about 1.6 million deaths were directly associated with diabetes, which was around 2.2 million in 2012.
    Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. WHO projects that diabetes is likely to be the seventh-leading cause of death by 2030.
    The growing prevalence of diabetes is the major driver for the global diabetes care devices market. Additionally, rising awareness regarding diabetes care, growing prevalence of obesity, and technological advancements are further driving the market for diabetes care devices.

    North America to Dominate the Monitoring Devices Segment

    The factors attributing to the North American market growth is the rising prevalence of diabetes, caused mainly due to urbanization and sedentary lifestyles.
    Asia-Pacific is anticipated to grow tremendously during the forecast period, owing to factors, such as a high prevalence of diabetes, growing obese population, and government initiatives of raising awareness regarding diabetic care.

    Diabetes Care Devices Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 6000 USD for single user license) – https://www.industryresearch.co/purchase/13999757

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Diabetes Care Devices Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Monitoring Devices
    5.1.1 Self-Monitoring Blood Glucose Devices
    5.1.1.1 By Component (Value and Volume, 2012 – 2024)
    5.1.1.1.1 Glucometer Devices
    5.1.1.1.2 Test Strips
    5.1.1.1.3 Lancets
    5.1.1.2 By End User
    5.1.1.2.1 Hospital (Value and Volume, 2012 – 2024)
    5.1.1.2.1.1 Glucometer Devices
    5.1.1.2.1.2 Test Strips
    5.1.1.2.1.3 Lancets
    5.1.1.2.2 Personal (Value and Volume, 2012 – 2024)
    5.1.1.2.2.1 Glucometer Devices
    5.1.1.2.2.2 Test Strips
    5.1.1.2.2.3 Lancets
    5.1.2 Continuous Blood Glucose Monitoring
    5.1.2.1 By Component (Value and Volume, 2012 – 2024)
    5.1.2.1.1 Sensors
    5.1.2.1.2 Receivers
    5.2 Management Devices
    5.2.1 Insulin Pump
    5.2.1.1 Insulin Pump Device
    5.2.1.2 Insulin Pump Reservoir
    5.2.1.3 Infusion Set
    5.2.2 Insulin Syringes
    5.2.3 Insulin Cartridges
    5.2.4 Disposable Pens
    5.2.5 Jet Injectors
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States (Value and Volume, 2012 – 2024)
    5.3.1.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.1.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.1.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.1.2 Canada (Value and Volume, 2012 – 2024)
    5.3.1.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.1.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.1.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.1.3 Rest of North America (Value and Volume, 2012 – 2024)
    5.3.1.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.1.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.1.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2 Europe
    5.3.2.1 France (Value and Volume, 2012 – 2024)
    5.3.2.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.2 Germany (Value and Volume, 2012 – 2024)
    5.3.2.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.3 Italy (Value and Volume, 2012 – 2024)
    5.3.2.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.4 Spain (Value and Volume, 2012 – 2024)
    5.3.2.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.5 United Kingdom (Value and Volume, 2012 – 2024)
    5.3.2.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.6 Russia (Value and Volume, 2012 – 2024)
    5.3.2.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.7 Rest of Europe (Value and Volume, 2012 – 2024)
    5.3.2.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.7.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.3 Latin America
    5.3.3.1 Mexico (Value and Volume, 2012 – 2024)
    5.3.3.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.3.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.3.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.3.2 Brazil (Value and Volume, 2012 – 2024)
    5.3.3.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.3.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.3.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.3.3 Rest of Latin America (Value and Volume, 2012 – 2024)
    5.3.3.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.3.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.3.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4 Asia-Pacific
    5.3.4.1 Japan (Value and Volume, 2012 – 2024)
    5.3.4.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.2 South Korea (Value and Volume, 2012 – 2024)
    5.3.4.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.3 China (Value and Volume, 2012 – 2024)
    5.3.4.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.4 India (Value and Volume, 2012 – 2024)
    5.3.4.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.5 Australia (Value and Volume, 2012 – 2024)
    5.3.4.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.6 Vietnam (Value and Volume, 2012 – 2024)
    5.3.4.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.7 Malaysia (Value and Volume, 2012 – 2024)
    5.3.4.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.7.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.8 Indonesia (Value and Volume, 2012 – 2024)
    5.3.4.8.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.8.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.8.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.9 Philippines (Value and Volume, 2012 – 2024)
    5.3.4.9.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.9.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.9.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.10 Thailand (Value and Volume, 2012 – 2024)
    5.3.4.10.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.10.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.10.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2012 – 2024)
    5.3.4.11.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.11.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.11.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5 Middle East & Africa
    5.3.5.1 Saudi Arabia (Value and Volume, 2012 – 2024)
    5.3.5.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.2 Iran (Value and Volume, 2012 – 2024)
    5.3.5.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.3 Egypt (Value and Volume, 2012 – 2024)
    5.3.5.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.4 Oman (Value and Volume, 2012 – 2024)
    5.3.5.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.5 South Africa (Value and Volume, 2012 – 2024)
    5.3.5.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.6 Rest of Middle & Africa (Value and Volume, 2012 – 2024)
    5.3.5.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)

    6 MARKET INDICATORS
    6.1 Type 1 Diabetes Population (2012-2024)
    6.2 Type 2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Abbott Diabetes Care
    7.1.2 Roche
    7.1.3 Johnson & Johnson
    7.1.4 Dexcom
    7.1.5 Medtronic
    7.1.6 Arkray
    7.1.7 Ascensia Diabetes Care
    7.1.8 Agamatrix Inc.
    7.1.9 Bionime Corporation
    7.1.10 Acon
    7.1.11 Medisana
    7.1.12 Trivida
    7.1.13 Rossmax
    7.2 COMPANY SHARE ANALYSIS
    7.2.1 Roche
    7.2.2 Johnson & Johnson
    7.2.3 Abbott Diabetes Care
    7.2.4 Dexcom
    7.2.5 Medtronic
    7.2.6 Novo Nordisk
    7.2.7 Eli Lilly
    7.2.8 Sanofi
    7.2.9 Others

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Bacillus Coagulans Market Size & Share 2019 – Review, Key Findings, Company Profiles, Complete Analysis, Growth Strategy, Developing Technologies, Trends and Forecast by Regions

    Alpha-Methylstyrene (AMS) Market 2019 Industry Business Challenges, Share, Geographical Segmentation, Consumption Status and Opportunity Analysis: World Market Outlook to 2026

    Spiral Wound Gaskets Market 2019 | Top Leading Countries with Industry Size, Companies, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2023

    PVC Floors Market 2019 |Global Industry Analysis by Trends, Size, Share, Company Overview, Growth and Forecast by 2023 | Latest Research Report by Industry Research.co